The use of clobazam as an adjunctive treatment for lennox-gastaut syndrome

Drugs of Today

Volumn 48, Issue 11, 2012, Pages 697-703

  Owen, R T ^a  

^a Freelance Medical Writer   (United Kingdom)

Author keywords

Antiepileptic drugs; Clobazam; Lennox Gastaut syndrome; Seizure disorders

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALPHA HYDROXYMIDAZOLAM; CAFFEINE; CLOBAZAM; CYTOCHROME P450 2C19; DEXTROMETHORPHAN; KETOCONAZOLE; LAMOTRIGINE; MIDAZOLAM; NORCLOBAZAM; OMEPRAZOLE; TOLBUTAMIDE; VALPROIC ACID;

ABNORMAL BEHAVIOR; ADJUVANT THERAPY; AGGRESSION; AREA UNDER THE CURVE; ATAXIA; BRAIN DISEASE; CHOREA; CONSTIPATION; CONVULSION; COUGHING; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEVER; FOOD AND DRUG ADMINISTRATION; GENOTYPE; HUMAN; HYPERSALIVATION; INSOMNIA; IRRITABILITY; LENNOX GASTAUT SYNDROME; LETHARGY; LOW DRUG DOSE; MAXIMUM PLASMA CONCENTRATION; PHARMACOGENOMICS; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; REVIEW; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; SOMNOLENCE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANTICONVULSANTS; BENZODIAZEPINES; DRUG INTERACTIONS; HUMANS; INTELLECTUAL DISABILITY; SPASMS, INFANTILE; TREATMENT OUTCOME;

EID: 84870194610     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2012.48.11.1879453     Document Type: Review

References (28)

1. Niedermayer, E. The Lennox-Gastaut syndrome, a severe type of childhood epilepsy. Dtsch Z Nervenheilk 1969, 195: 263-82.
2. Lennox, W.G., Davis, J.P. Clinical correlates of the fast and slow spike-wave electroencephalogram. Pediatrics 1950, 5(4): 626-44.
3. Gastaut, H., Roger, J., Soulayrol, R. et al. Childhood epileptic encephalopathy with diffuse slow spike waves (otherwise known as ''petit mal variant'') or Lennox syndrome. Epilepsia 1966, 7(2): 139-79.
4. Arzimanoglou, A., French, J., Blume, W.T. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management and trial methodology. Lancet Neurol 2009, 8(1): 82-93.
5. Crumrine, P.L. Lennox-Gastaut syndrome. J Child Neurol 2002, 17(Suppl.): S70-5.
6. van Rijkevarsel, K. Treatment of Lennox-Gastaut syndrome: overview and recent findings. Neuropsychiatr Dis Treat 2008, 4(6): 1001-9.
7. Markland, O.N. Lennox-Gastaut syndrome (childhood epileptic encephalopathy). J Clin Neurophysiol 2003, 20(6): 426-41.
8. Ng, Y-T., Collins, S.D. Clobazam. Neurotherapeutics 2007, 4(1): 138-44. (Pubitemid 46107321)
9. Onfi™ US Prescribing Information. http://www.lundbeck.com/ upload/us/files/pdf/Products/Onfi-PI-US-EN.pdf. Accessed August 12, 2012.
10. Molecular regulation of glutamate and GABA transported proteins by clobazam during epileptogenesis in Fe (+++)- induced epileptic rats. Brain Res Mol Brain Res 2005, 142(2): 91-6.
11. Kinoshita, M., Ikeda, A., Begum, T., Terada, K., Shibasaki, H. Efficacy of low-dose, add-on therapy of clobazam is produced by its major metabolite N-desmethylclobazam. J Neurol Sci 2007, 263(1-2): 44-8. (Pubitemid 350029828)
12. Haigh, J.R.M., Pullar, T., Gent, J.P., Dailley, C., Feely, M. N-Desmethylclobazam: a possible alternative to clobazam in the treatment of refractory epilepsy. Br J Clin Pharmacol 1987, 23(2): 213-8. (Pubitemid 17113499)
13. Walzer, M., Bekersky, I., Blum, R.A., Tolbert, D. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes. Pharmacotherapy 2012, 32(4): 527-37.
14. Seo, T., Nagata, R., Ishitu, T. et al. Impact of CYP2C19 polymorphisms on the efficacy of clobazam therapy. Pharmacogenomics 2008, 9(5): 527-37. (Pubitemid 351803914)
15. Ng, Y-T., Conry, J.A., Drummond, R., Stolle, J., Weinberg, M.A. Randomized phase II study results of clobazam in Lennox-Gastaut syndrome. Neurology 2011, 77(15): 1473-81.
16. Conry, J.A., Ng, Y-T., Paolicchi, J.M. et al. Clobazam in the treatment of Lennox-Gastaut syndrome. Epilepsia 2009, 50(5): 1158-66.
17. FDA Drug Approval Package (Medical Review) on Onfi™http://www. accessdata.fda.gov/drugsatfda-docs/nda/2011/202067Orig1s000MedR.pdf. Accessed August 12, 2012.
18. Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993, 328(1): 29-33.
19. Motte, J., Treviathan, E., Arvidsson, J.F. et al. Lamotrigine for generalized seizures associated with Lennox-Gastaut syndrome. N Engl J Med 1997, 337(25): 1807-12. (Pubitemid 28006785)
20. th Annu Meet Am Acad Neurol (AAN) (April 9-16, Miami Beach) 2005] 2005, Abst LBS.001.
21. Sachdeo, R.C., Glauser, T.A., Ritter, R., Reife, R., Lim, P., Pledger, G. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology 1999, 52(9): 1882-7. (Pubitemid 29260904)
22. US Prescribing Information on clonazepam (Klonopin®) http://www.gene.com/gene/products/information/klonopin/pdf/pi.pdf. Accessed August 12, 2012.
23. Vassella, F., Pavlincova, E., Schneider, H.J., Rudin, H.J., Karbowski, K. Treatment of infantile spasms and Lennox-Gastaut syndrome with clonazepam. Epilepsia 1973, 14(2): 165-75.
24. Tassinari, C.A., Dravet, C., Roger, J., Cano, J.P., Gastaut, H. Tonic status epilepticus precipitated by intravenous benzodiazepines in 5 patients with Lennox-Gastaut syndrome. Epilepsia 1972, 13(3): 421-35.
25. DiMario, F.J. Jr., Clancy, R.R. Paradoxical precipitation of tonic seizures by lorazepam in a child with atypical absence seizures. Pediatr Neurol 1988, 4(4): 249-51.
26. Mills, J.K.A., Lewis, T.B., Mughal, K., Ali, I., Ugur, A., Whitehouse, W.P. Retention rate of clobazam, topiramate and lamotrigine in children with intactable epilepsies at 1 year. Seizure 2011, 20(5): 402-5.
27. Doongaji, D.R., Sheth, A., Apte, J.S., Lakdawala, P.D., Khare, C.B., Thatte, S.S. Clobazam versus diazepam: a double-blind study in anxiety neurosis. J Clin Pharmacol 1978, 18(7): 358-64. (Pubitemid 8381711)
28. Biehl, B. Clobazam and car driving. Br J Clin Pharmacol 1979, 7(Suppl. 1): 85S-9S.